Ras-Driven Transformation of Human Nestin-Positive Pancreatic Epithelial Cells

Methods in Enzymology

Volumn 439, Issue , 2008, Pages 451-465

  Campbell, Paul M ^a   Lee, Kwang M ^b   Ouellette, Michel M ^b   Kim, Hong Jin ^a   Groehler, Angela L ^a   Khazak, Vladimir ^c   Der, Channing J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NexusPharma Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NESTIN; RAF PROTEIN; RAS PROTEIN; INTERMEDIATE FILAMENT PROTEIN; KRAS PROTEIN, HUMAN; NERVE PROTEIN; ONCOPROTEIN;

ANTINEOPLASTIC ACTIVITY; CELL TRANSFORMATION; EPITHELIUM CELL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; MIGRATION; NONHUMAN; ONCOGENE RAS; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; SIMIAN VIRUS 40; SUPERNATANT; ARTICLE; CELL CULTURE; CYTOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PANCREATIC DUCTS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 45549084608     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)00431-4     Document Type: Review

References (47)

1. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., and DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev. 17 (2003) 3112-3126
2. Ahrendt S.A., and Pitt H.A. Surgical management of pancreatic cancer. Oncology 16 (2002) 725-734 discussion 734, 736-738, 740, 743
3. Allison D.C., Piantadosi S., Hruban R.H., Dooley W.C., Fishman E.K., Yeo C.J., Lillemoe K.D., Pitt H.A., Lin P., and Cameron J.L. DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma. J. Surg. Oncol. 67 (1998) 151-159
4. Brembeck F.H., Schreiber F.S., Deramaudt T.B., Craig L., Rhoades B., Swain G., Grippo P., Stoffers D.A., Silberg D.G., and Rustgi A.K. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res. 63 (2003) 2005-2009
5. Campbell P.M., Groehler A.L., Lee K.M., Ouellette M.M., Khazak V., and Der C.J. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res. 67 (2007) 2098-2106
6. Campbell P.M., and Szyf M. Human DNA methyltransferase gene DNMT1 is regulated by the APC pathway. Carcinogenesis 24 (2003) 17-24
7. Carriere C., Seeley E.S., Goetze T., Longnecker D.S., and Korc M. The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc. Natl. Acad. Sci. USA 104 (2007) 4437-4442
8. Cox A.D., and Der C.J. Ras family signaling: Therapeutic targeting. Cancer Biol. Ther. 1 (2002) 599-606
9. Delacour A., Nepote V., Trumpp A., and Herrera P.L. Nestin expression in pancreatic exocrine cell lineages. Mech. Dev. 121 (2004) 3-14
10. Dutta S., Gannon M., Peers B., Wright C., Bonner-Weir S., and Montminy M. PDX:PBX complexes are required for normal proliferation of pancreatic cells during development. Proc. Natl. Acad. Sci. USA 98 (2001) 1065-1070
11. Elenbaas B., Spirio L., Koerner F., Fleming M.D., Zimonjic D.B., Donaher J.L., Popescu N.C., Hahn W.C., and Weinberg R.A. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15 (2001) 50-65
12. Fernandes A., King L.C., Guz Y., Stein R., Wright C.V., and Teitelman G. Differentiation of new insulin-producing cells is induced by injury in adult pancreatic islets. Endocrinology 138 (1997) 1750-1762
13. Fiordalisi J.J., Johnson II R.L., Ulkü A.S., Der C.J., and Cox A.D. Mammalian expression vectors for Ras family proteins: Generation and use of expression constructs to analyze Ras family function. Methods Enzymol. 332 (2001) 3-36
14. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 400 (1999) 464-468
15. Hahn W.C., and Weinberg R.A. Rules for making human tumor cells. N. Engl. J. Med. 347 (2002) 1593-1603
16. Halbert C.L., Demers G.W., and Galloway D.A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65 (1991) 473-478
17. Herrera P.L., Nepote V., and Delacour A. Pancreatic cell lineage analyses in mice. Endocrine 19 (2002) 267-278
18. Hingorani S.R., Wang L., Multani A.S., Combs C., Deramaudt T.B., Hruban R.H., Rustgi A.K., Chang S., and Tuveson D.A. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7 (2005) 469-483
19. Hruban R.H., Goggins M., Parsons J., and Kern S.E. Progression model for pancreatic cancer. Clin. Cancer Res. 6 (2000) 2969-2972
20. Hruban R.H., Wilentz R.E., and Kern S.E. Genetic progression in the pancreatic ducts. Am. J. Pathol. 156 (2000) 1821-1825
21. Hunziker E., and Stein M. Nestin-expressing cells in the pancreatic islets of Langerhans. Biochem. Biophys. Res. Commun. 271 (2000) 116-119
22. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., Feuer E.J., and Thun M.J. Cancer statistics, 2005. CA Cancer J. Clin. 55 (2005) 10-30
23. Jesnowski R., Müller P., Schareck W., Liebe S., and Löhr M. Immortalized pancreatic duct cells in vitro and in vivo. Ann. N.Y. Acad. Sci. 880 (1999) 50-65
24. Kato-Stankiewicz J., Hakimi I., Zhi G., Zhang J., Serebriiskii I., Guo L., Edamatsu H., Koide H., Menon S., Eckl R., Sakamuri S., Lu Y., et al. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Proc. Natl. Acad. Sci. USA 99 (2002) 14398-14403
25. Lee K.M., Nguyen C., Ulrich A.B., Pour P.M., and Ouellette M.M. Immortalization with telomerase of the Nestin-positive cells of the human pancreas. Biochem. Biophys. Res. Commun. 301 (2003) 1038-1044
26. Lee K.M., Yasuda H., Hollingsworth M.A., and Ouellette M.M. Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells. Lab. Invest. 85 (2005) 1003-1012
27. Linetsky E., Bottino R., Lehmann R., Alejandro R., Inverardi L., and Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 46 (1997) 1120-1123
28. Listrom M.B., and Dalton L.W. Comparison of keratin monoclonal antibodies MAK-6, AE1:AE3, and CAM-5.2. Am. J. Clin. Pathol. 88 (1987) 297-301
29. Maione R., Fimia G.M., and Amati P. Inhibition of in vitro myogenic differentiation by a polyomavirus early function. Oncogene 7 (1992) 85-93
30. Malumbres M., and Barbacid M. RAS oncogenes: The first 30 years. Nat. Rev. Cancer 3 (2003) 459-465
31. Miller A.D., and Rosman G.J. Improved retroviral vectors for gene transfer and expression. Biotechniques 7 (1989) 980-982 984-986, 989-990
32. Morgenstern J.P., Land H.,. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18 (1990) 3587-3596
33. Münger K., Werness B.A., Dyson N., Phelps W.C., Harlow E., and Howley P.M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J. 8 (1989) 4099-4105
34. Nakamura T.M., Morin G.B., Chapman K.B., Weinrich S.L., Andrews W.H., Lingner J., Harley C.B., and Cech T.R. Telomerase catalytic subunit homologs from fission yeast and human. Science 277 (1997) 955-959
35. Ouellette M.M., Aisner D.L., Savre-Train I., Wright W.E., and Shay J.W. Telomerase activity does not always imply telomere maintenance. Biochem. Biophys. Res. Commun. 254 (1999) 795-803
36. Peterson S.N., Trabalzini L., Brtva T.R., Fischer T., Altschuler D.L., Martelli P., Lapetina E.G., Der C.J., and White II G.C. Identification of a novel RalGDS-related protein as a candidate effector for Ras and Rap1. J. Biol. Chem. 271 (1996) 29903-29908
37. Repasky G.A., Chenette E.J., and Der C.J. Renewing the conspiracy theory debate: Does Raf function alone to mediate Ras oncogenesis?. Trends Cell Biol. 14 (2004) 639-647
38. Selander L., and Edlund H. Nestin is expressed in mesenchymal and not epithelial cells of the developing mouse pancreas. Mech. Dev. 113 (2002) 189-192
39. Sontag E., Fedorov S., Kamibayashi C., Robbins D., Cobb M., and Mumby M. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75 (1993) 887-897
40. Soreide K., Janssen E.A., Körner H., and Baak J.P. Trypsin in colorectal cancer: Molecular biological mechanisms of proliferation, invasion, and metastasis. J. Pathol. 209 (2006) 147-156
41. Valster A., Tran N.L., Nakada M., Berens M.E., Chan A.Y., and Symons M. Cell migration and invasion assays. Methods 37 (2005) 208-215
42. Vilá M.R., Balagué C., and Real F.X. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl. Pathol. 140 (1994) 225-235
43. Warshaw A.L., and Fernandez-del Castillo C. Pancreatic carcinoma. N. Engl. J. Med. 326 (1992) 455-465
44. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
45. Wolthuis R.M., Zwartkruis F., Moen T.C., and Bos J.L. Ras-dependent activation of the small GTPase Ral. Curr. Biol. 8 (1998) 471-474
46. Yeh J.J., and Der C.J. Targeting signal transduction in pancreatic cancer treatment. Expert Opin. Ther. Targets 11 (2007) 673-694
47. Zulewski H., Abraham E.J., Gerlach M.J., Daniel P.B., Moritz W., Müller B., Vallejo M., Thomas M.K., and Habener J.F. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 50 (2001) 521-533